Before CBD was discussed by a President in the Oval Office, it was a medical necessity.

The Charlotte Figi story is well documented — and powerful.
Not because it was emotional, but because it forced a serious medical conversation.

Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.

Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.

This week, we sit down with Bill Morachnick to break down:

• Why CBD earned acceptance through medical trust, not consumer marketing
• How physician comfort, reimbursement pathways, and standards changed the conversation
• CBD in the Oval Office — and what that signals for the future of cannabis

 

Chapters

00:00 Introduction to Charlotte's Web and Bill Morachnick

03:00 The Inspiring Story of Charlotte Figi

05:51 The Executive Order and Its Implications

08:59 The Role of Education in CBD Acceptance

12:12 Challenges and Misconceptions in the Cannabis Industry

15:03 The Future of CBD and Medical Recommendations

18:06 The Impact of Federal Reimbursement on CBD

21:08 Defloria and the Future of Cannabis Research

24:01 Navigating Regulatory Changes and Industry Challenges

27:03 The Importance of Quality and Consistency in CBD Products

30:02 The Potential for Pharmaceutical Collaborations

33:04 Looking Ahead: The Future of CBD and Cannabis

36:13 Final Thoughts and Audience Engagement

Summary

In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.

Guest Links:

• https://www.trycharlottesweb.com/
• https://www.charlottesweb.com/
• https://www.youtube.com/charlotteswebcbd
• https://www.instagram.com/charlotteswebcbd/
• https://www.linkedin.com/in/bill-morachnick-01318a6/
• https://www.linkedin.com/company/charlottesweb/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.